These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 505362)

  • 21. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy.
    Egberg N; Bergström K
    Haemostasis; 1978; 7(2-3):85-91. PubMed ID: 149049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
    Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
    Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].
    Koie K; Kamiya T; Takamatsu J; Hayashi K; Saito H
    Rinsho Ketsueki; 1980 Jun; 21(6):704-13. PubMed ID: 6450843
    [No Abstract]   [Full Text] [Related]  

  • 24. Assaying plasma prekallikrein (PPK) by a chromogenic based method: analytical considerations and reference values in healthy adults, the pregnant woman, and the neonate.
    Ito R; Statland BE; Sher G; Knutzen V
    Adv Exp Med Biol; 1983; 156():205-23. PubMed ID: 6552838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (factor XII): report of a case with observation on in vivo and in vitro leukocyte chemotaxis.
    Poon MC; Moore MR; Castleberry RP; Lurie A; Huang ST; Lehmeyer J
    Am J Hematol; 1982 May; 12(3):261-70. PubMed ID: 6919394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency].
    Iijima K; Nakamura K
    Rinsho Ketsueki; 1989 Oct; 30(10):1702-7. PubMed ID: 2593236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromogenic substrate assay of plasma prekallikrein. With a note on its site of biosynthesis.
    Stormorken H; Baklund A; Gallimore M; Ritland S
    Haemostasis; 1978; 7(2-3):69-75. PubMed ID: 26628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
    Schmaier AH; Gustafson E; Idell S; Colman RW
    J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation factor deficiency apparently related to the Fitzgerald trait: the first cases in Japan.
    Hayashi H; Koya H; Kitajima K; Kimura I
    Acta Med Okayama; 1978 Apr; 32(1):81-3. PubMed ID: 148837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved methods to assay contact activation.
    Soulier JP; Gozin D
    Adv Biosci; 1978 Jul; 17():271-80. PubMed ID: 755703
    [No Abstract]   [Full Text] [Related]  

  • 31. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay of prekallikrein in human plasma: comparison of amidolytic, esterolytic, coagulation, and immunochemical assays.
    Fisher CA; Schmaier AH; Addonizio VP; Colman RW
    Blood; 1982 May; 59(5):963-70. PubMed ID: 6803857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis].
    Marongiu F; Mamusa AM; Solinas A; Demelia L; Mulas G; Perpignano G
    Haematologica; 1982; 67(6):926-30. PubMed ID: 6819198
    [No Abstract]   [Full Text] [Related]  

  • 34. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion.
    Vicente V; Alberca I; Gonzalez R; Alegre A; Redondo C; Moro J
    Haematologia (Budap); 1986; 19(1):41-8. PubMed ID: 3636267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contact activation of prekallikrein and of fibrinolysis by heparinoids and heparin.
    Soulier JP; Gozin D
    Haematologia (Budap); 1980; 13(1-4):117-28. PubMed ID: 6166520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a microassay for human plasma prekallikrein.
    De La Cadena RA; Scott CF; Colman RW
    J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J; Huyke R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):492-6. PubMed ID: 6083916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.